These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 26092622)

  • 41. Gene therapy for therapeutic angiogenesis in peripheral arterial disease - a systematic review and meta-analysis of randomized, controlled trials.
    Hammer A; Steiner S
    Vasa; 2013 Sep; 42(5):331-9. PubMed ID: 23989068
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risk of recurrent venous thromboembolism in patients with common thrombophilia: a systematic review.
    Ho WK; Hankey GJ; Quinlan DJ; Eikelboom JW
    Arch Intern Med; 2006 Apr; 166(7):729-36. PubMed ID: 16606808
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ocular artery thrombosis as an initial presentation of a prothrombin G20210A mutation.
    Parc C; Tiberghien E; Pierre-Kahn V
    J Fr Ophtalmol; 2010 Jun; 33(6):380-2. PubMed ID: 20493583
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A.
    Lijfering WM; Middeldorp S; Veeger NJ; Hamulyák K; Prins MH; Büller HR; van der Meer J
    Circulation; 2010 Apr; 121(15):1706-12. PubMed ID: 20368522
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk factors for clinical manifestations in carriers of Factor V Leiden and prothrombin gene mutations.
    DeSancho MT; Berlus N; Christos PJ; Rand J
    Blood Coagul Fibrinolysis; 2010 Jan; 21(1):11-5. PubMed ID: 19474699
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Thrombophilic mutations in high-risk atrial fibrillation patients: high prevalence of prothrombin gene G20210A polymorphism and lack of correlation with thromboembolism.
    Poli D; Antonucci E; Cecchi E; Betti I; Valdrè L; Mugnaini C; Alterini B; Morettini A; Nozzoli C; Abbate R; Gensini GF; Prisco D
    Thromb Haemost; 2003 Dec; 90(6):1158-62. PubMed ID: 14652651
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
    Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
    Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phenotypic APC resistance in carriers of the A20210 prothrombin mutation is associated with an increased risk of venous thrombosis.
    Castaman G; Tosetto A; Simioni M; Ruggeri M; Madeo D; Rodeghiero F
    Thromb Haemost; 2001 Sep; 86(3):804-8. PubMed ID: 11583311
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Matched case-control study on factor V Leiden and the prothrombin G20210A mutation in patients with ischemic stroke/transient ischemic attack up to the age of 60 years.
    Lalouschek W; Schillinger M; Hsieh K; Endler G; Tentschert S; Lang W; Cheng S; Mannhalter C
    Stroke; 2005 Jul; 36(7):1405-9. PubMed ID: 15947254
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prothrombin G20210A mutation is associated with young-onset stroke: the genetics of early-onset stroke study and meta-analysis.
    Jiang B; Ryan KA; Hamedani A; Cheng Y; Sparks MJ; Koontz D; Bean CJ; Gallagher M; Hooper WC; McArdle PF; O'Connell JR; Stine OC; Wozniak MA; Stern BJ; Mitchell BD; Kittner SJ; Cole JW
    Stroke; 2014 Apr; 45(4):961-7. PubMed ID: 24619398
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevalence of frailty in patients with lower extremity peripheral arterial disease: A systematic review and meta-analysis.
    Wang Y; Wu X; Hu X; Yang Y
    Ageing Res Rev; 2022 Dec; 82():101748. PubMed ID: 36216291
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A meta-analysis to compare Dacron versus polytetrafluroethylene grafts for above-knee femoropopliteal artery bypass.
    Rychlik IJ; Davey P; Murphy J; O'Donnell ME
    J Vasc Surg; 2014 Aug; 60(2):506-15. PubMed ID: 24973288
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Can inherited thrombophilia modulate the clinical phenotype of patients with antiphospholipid syndrome?
    Berman H; Ugarte-Gil MF; Espinosa G; Tàssies D; Monteagudo J; Reverter JC; Cervera R
    Clin Exp Rheumatol; 2013; 31(6):926-32. PubMed ID: 24093662
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevention of ischemic events in patients with peripheral arterial disease design, baseline characteristics and 2-year results an observational study.
    Blinc A; Kozak M; Sabovic M; Božic M; Stegnar M; Poredoš P; Kravos A; Barbic-Žagar B; Pohar Perme M; Stare J;
    Int Angiol; 2011 Dec; 30(6):555-66. PubMed ID: 22233617
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [A Meta-analysis of prothrombin G20210A polymorphism and its risk for sudden sensorineural hearing loss].
    Liu B; Feng WJ; Peng XX; Yang J
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 May; 48(5):417-21. PubMed ID: 24016568
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Are patients with thrombophilia and previous venous thromboembolism at higher risk to arterial thrombosis?
    Linnemann B; Schindewolf M; Zgouras D; Erbe M; Jarosch-Preusche M; Lindhoff-Last E
    Thromb Res; 2008; 121(6):743-50. PubMed ID: 17804043
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association between the prothrombin G20210A mutation and sudden sensorineural hearing loss in European population: a meta-analysis.
    Shu J; Yin S; Tan AZ; He M
    Thromb Res; 2015 Jan; 135(1):73-7. PubMed ID: 25466842
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dual antiplatelet therapy is associated with prolonged survival after lower extremity revascularization.
    Soden PA; Zettervall SL; Ultee KH; Landon BE; O'Malley AJ; Goodney PP; DeMartino RR; Arya S; Schermerhorn ML;
    J Vasc Surg; 2016 Dec; 64(6):1633-1644.e1. PubMed ID: 27575814
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Allele 4G of gene PAI-1 associated with prothrombin mutation G20210A increases the risk for venous thrombosis.
    Barcellona D; Fenu L; Cauli C; Pisu G; Marongiu F
    Thromb Haemost; 2003 Dec; 90(6):1061-4. PubMed ID: 14652637
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association of the prothrombin G20210A mutation with factor V Leiden in a midwestern American population.
    Bavikatty NR; Killeen AA; Akel N; Normolle D; Schmaier AH
    Am J Clin Pathol; 2000 Aug; 114(2):272-5. PubMed ID: 10941343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.